Print this page
Lunes, 24 Octubre 2022 10:32

Camacho Sanchez, John Alexander

Written by 
Rate this item
(1 Vote)

  //  DOCENTE OCASIONAL  //

Maestría en Ingeniería de Sistemas y Computación

pregrado

Ingeniero Electrónico

perfil LinkedIn

Read 1047403 times Last modified on Lunes, 24 Octubre 2022 10:48

88849 comments

  • Comment Link Diflucan (Fluconazole) Viernes, 30 Enero 2026 19:03 posted by Diflucan (Fluconazole)

    Diflucan can increase phenytoin levels, risking toxicity.

  • Comment Link Fluconazole (Diflucan) Viernes, 30 Enero 2026 19:01 posted by Fluconazole (Diflucan)

    Diflucan is used in the management of some cases of chronic disseminated candidiasis.

  • Comment Link Diflucan Viernes, 30 Enero 2026 19:01 posted by Diflucan

    The high oral bioavailability of Diflucan makes it exceptionally convenient for outpatient step-down therapy.

  • Comment Link Fluconazole Viernes, 30 Enero 2026 19:00 posted by Fluconazole

    Concomitant use with calcium channel blockers can lead to excessive hypotension and edema.

  • Comment Link Diflucan Viernes, 30 Enero 2026 18:59 posted by Diflucan

    Diflucan's role has been defined by large, randomized controlled trials in HIV and ICU populations.

  • Comment Link Diflucan Viernes, 30 Enero 2026 18:59 posted by Diflucan

    Alopecia is a reversible but distressing side effect reported with prolonged use.

  • Comment Link Fluconazole (Diflucan) Viernes, 30 Enero 2026 18:57 posted by Fluconazole (Diflucan)

    The long half-life (~30 hours) enables convenient once-daily dosing regimens.

  • Comment Link Diflucan Viernes, 30 Enero 2026 18:54 posted by Diflucan

    Therapeutic drug monitoring for Diflucan is not routine but can guide therapy in complex cases.

  • Comment Link Fluconazole Viernes, 30 Enero 2026 18:51 posted by Fluconazole

    Breakthrough infections during prophylaxis are a significant clinical red flag.

  • Comment Link Diflucan Viernes, 30 Enero 2026 18:50 posted by Diflucan

    Therapeutic success relies heavily on host immune status and source control.